Articles

Science & Innovation

Developing a Path Forward in Cancer Cachexia

Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions, such as cancer, and characterized by severe weight loss, decreased appetite, fatigue, and muscle wasting. Its symptoms can often be misattributed, and there are currently no FDA-approved treatments targeting its root cause.But, over the past decade, the...

Health Answers by Pfizer Launches Spanish-Language Expansion

Back in February, we launched Health Answers by Pfizer, a consumer digital experience powered by generative AI that provides clear, relevant answers to health & wellness questions, and helps consumers take action for themselves and their loved ones.Today, we’re proud to announce a major step forward: Health Answers by Pfizer is now available in Spanish. With this new release, Spanish-speaking consumers across the U.S. can access trusted, personalized health information in the language they know...

September Social Media Round-Up—Fast Company, Prostate Cancer Awareness Month, and More

Pfizer kicked off fall with some major milestones. Catch up on the latest happenings across our social media to learn more.On our corporate channels we shared important patient stories and tips for Prostate Cancer and Blood Cancer Awareness Month, released a new episode of “Living Fully with Ulcerative Colitis,” and even launched a new series, “Partnerships with Purpose.”CEO Albert Bourla announced Pfizer’s agreement to acquire Metsera, welcomed a new Chief Scientific Officer of Internal...

The Power of Knowing, Episode 3: Arianna Huffington

Over the summer, Pfizer launched “The Power of Knowing” video series that explores artificial intelligence and the ways it’s impacting the business world. The series features interviews with the men and women leading the charge, and shares their insights into the myriad ways AI is transforming the world.In the debut episode of The Power of Knowing, host Lidia Fonseca, Pfizer’s Chief Digital and Technology Officer, sat down with Stan McChrystal, Retired US Army General and Co-Founder of the...

Expanding Global Impact with Dr. Sue Desmond-Hellman: The Power of Knowing, Episode Two

To explore how AI is transforming the way we work, lead, and shape the future, earlier this year, Pfizer launched “The Power of Knowing,” a new video series that explores the burgeoning technology’s evolving role in all our lives.  Hosted by Lidia Fonseca, Pfizer’s Chief Digital and Technology Officer, the series features conversations with visionary leaders as they explore how AI and other breakthrough technologies are changing the world—unlocking innovation, driving digital transformation, and...

Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer

Once confined to the realms of science and research, artificial intelligence (AI) has quickly become a part of our day-to-day lives. As the technology continues to grow, integrating itself into all corners of modern life, one thing is for certain: there’s no avoiding it.Here at Pfizer, we’re continuously exploring how AI can be leveraged in ways big and small as we pursue our goal of making breakthroughs that change patients' lives. Across our 176 years, from the mass production of penicillin to...

The Mindfulness of Medicine Development: A Scientist’s Work Is Never Done

At Pfizer, we know that breakthroughs aren’t created in a vacuum. Every new discovery, every new medicine and vaccine, is the result of the collaboration of many members of our community, each with their own unique experiences, expertise, and insights. The human element cannot be separated from our work any more than the patient experience can be removed from the outcome.“The Mindfulness of Medicine Development” series showcases the journeys, experiences, and inspirations of our colleagues...

The Mindfulness of Medicine Development: Patients as Partners in the R&D Journey

At Pfizer, we know that breakthroughs aren’t created in a vacuum. Every new discovery, every new medicine and vaccine, is the result of the collaboration of many members of our community, each with their own unique experiences, expertise, and insights. The human element cannot be separated from our work any more than the patient experience can be removed from the treatment. “The Mindfulness of Medicine Development” series showcases the journeys, experiences, and inspirations of our colleagues...

The Mindfulness of Medicine Development: The First Steps of Scientific Innovation

At Pfizer, we know that breakthroughs aren’t created in a vacuum. Every new discovery, every new medicine and vaccine, is the result of the collaboration of many members of our community, each with their own unique experiences, expertise, and insights. The human element cannot be separated from our work any more than the patient experience can be removed from the outcome.“The Mindfulness of Medicine Development” series showcases the journeys, experiences, and inspirations of our colleagues...

The Future of IBD Care: Pfizer Leads a New Era of Noninvasive Monitoring

At Pfizer, we are committed to improving care and addressing inequities for patients living with inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease.  And, for people living with IBD, regular monitoring of the bowel is important for tracking the disease activity and severity and adjusting treatments and care as needed.1 A colonoscopy—a procedure where doctors use a flexible camera to look inside a patient’s colon—has long been the most common method of...

Watch Pfizer’s SXSW Live Podcast Panels

Last month, Pfizer attended the South by Southwest festival in Austin, where we took over the podcast lounge for the second year in a row.Throughout the day, we presented three live podcast episodes in front of a packed SXSW audience, with each episode tackling a different topic that’s at the forefront of healthcare in 2025. Today we are happy to share video of those sessions.For more from Pfizer’s award-winning Science Will Win podcast series, check out the latest season here: https://link...

Science & Innovation

The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model

During the early months of 2020, decentralized modalities to conduct clinical trials went mainstream as a solution to a short-term problem: how to continue clinical trials amid pandemic closures. At Pfizer, however, remote trials and the use of digital tools to conduct clinical trials were implemented long before the pandemic. Increased adoption of modalities like telehealth visits became catalysts for how — and where — clinical research could be done.What's more, surveys show that participants...